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Glucose and glutamine are important energetic and biosynthetic nutrients for T and B lymphocytes. These cells consume both
nutrients at high rates in a function-dependentmanner. In other words, the pathways that control lymphocyte function and survival
directly control the glucose and glutamine metabolic pathways. Therefore, lymphocytes in different functional states reprogram
their glucose and glutaminemetabolism to balance their requirement forATP andmacromolecule production.The tight association
between metabolism and function in these cells was suggested to introduce the possibility of several pathologies resulting from the
inability of lymphocytes to meet their nutrient demands under a given condition. In fact, disruptions in lymphocyte metabolism
and function have been observed in different inflammatory, metabolic, and autoimmune pathologies. Regular physical exercise and
physical activity offer protection against several chronic pathologies, and this benefit has been associatedwith the anti-inflammatory
and immunomodulatory effects of exercise/physical activity. Chronic exercise induces changes in lymphocyte functionality and
substrate metabolism. In the present review, we discuss whether the beneficial effects of exercise on lymphocyte function in health
and disease are associated with modulation of the glucose and glutamine metabolic pathways.
1. Glucose and Glutamine Metabolism and
Lymphocyte Function
Activated lymphocytes undergo a rapid burst in cellular
proliferative, biosynthetic, and secretory activities and must
obtain metabolic substrates to attempt this dramatic increase
in metabolism [1]. Their insignificant intracellular store
of nutrients obligates lymphocytes to markedly increase
the uptake of metabolic substrates from their microenvi-
ronment [2]. Although lymphocytes are able to use glu-
cose, glutamine, ketone bodies, and fatty acids (FA), it
was determined that glucose and glutamine are quantita-
tively the most important fuel for activated lymphocytes
[3].
Regarding the new metabolic demands of activated lym-
phocytes, glucose is initially retained in the cell by phospho-
rylation into glucose 6-phosphate by hexokinases (HKs) [2].
From there, glucose 6-phosphate can be used as a substrate
by aerobic glycolysis or by the pentose-phosphate pathway
(PPP). In the PPP, glucose 6-phosphate serves to generate
ribose (for the synthesis of RNA and DNA) and NADPH (for
FA synthesis) [1, 2].
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For glucose 6-phosphate that enters aerobic glycolysis,
the molecule is converted to pyruvate, after which it can be
converted to lactate or acetyl-CoA or be fully oxidized [3].
The majority is converted to lactate (approximately 91%) [4–
7], while most of the remaining pyruvate is converted to
acetyl-CoA, which has a central role in membrane biogenesis
[8], serving as a precursor to phospholipids, cholesterol, and
triacylglycerol [1, 3]. Thus, only a small percentage of glucose
6-phosphate is fully oxidized in lymphocytes [3].
In this scenario, the removal of citrate (pyruvate con-
verted to acetyl-CoA plus oxaloacetate) from the tricar-
boxylic acid (TCA) cycle for biosynthetic reactions imposes
the need to continue replenishing intermediates to maintain
this cycle’s function [2, 9]. Thus, beyond glucose, activated
lymphocytes also increase their update of glutamine and
convert it to glutamate, which is in turn converted to 𝛼-
ketoglutarate via glutamate dehydrogenase [3]. In addition to
replenishing intermediates to maintain the TCA cycle using
glutamate, lymphocytes also convert glutamine to aspartate
and ammonia, providing biosynthetic precursors, purines,
and pyrimidines, for the synthesis of DNA and RNA [3].
Finally, a limited percentage of glutamine can be converted
to lactate or be fully oxidized [3]. In fact, although oxidative
phosphorylation still occurs in effector T lymphocytes [8], it
seems that, of the glutamine (and glucose) utilized by these
cells, only approximately 1.5% is oxidized [3].
In accordance with the importance of glucose and
glutamine in activated lymphocytes, early studies of these
cells demonstrated that, to meet the new bioenergetic
and biosynthetic demands imposed by activation, lympho-
cytes also increase the maximal activity levels of enzymes,
such as HK, glucose-6-phosphate dehydrogenase (G6PDH)
and phosphate-dependent glutaminase (GLUTase), which
are key enzymes in the glycolysis, pentose-phosphate, and
glutaminolysis pathways, respectively. The mitochondrial
enzyme citrate synthase (CS), an important enzyme in the
TCA cycle, is also affected [6, 7]. Comparatively, B cell
metabolism has been less well investigated than T cell
metabolism; however, the metabolic characteristics of both
lymphocyte types might be similar [2, 10].
An outstanding feature of lymphocytes is that these
cells utilize glucose and glutamine at high rates in a
strictly function-dependent manner [7]. Furthermore, more
recently, studies of direct modifications to T lymphocyte
metabolic pathways demonstrated thatmetabolic reprogram-
ming and lymphocyte activation are intricately linked, as
cellular metabolism was found to be directly controlled by
the signaling pathways that drive cell survival and activity
[10]. Notably, Pearce and colleagues [8] stated that the
reasons why T cells would adopt specific metabolic programs
and the impacts of such programs on cell function and
immunological responses were unclear.
In this sense, T lymphocytes adopt a metabolic program
that reflects their energetic and biosynthetic needs in specific
states, ranging from resting to memory cell conversion. For
resting lymphocytes, it is worth mentioning that, despite the
name, these cells continuously migrate through secondary
lymphoid tissues to maintain immune surveillance prior
to activation; to accomplish this activity, these cells rely
on the oxidative metabolism of glucose, amino acids, and
lipids [9]. However, as previously discussed, once activated,
lymphocytes grow, proliferate, differentiate, and adapt to
stress [8], and the mixed oxidative metabolism associated
with a na¨ıve resting state, which preferentially generates ATP,
does not support these new functions [11]. Thus, the priori-
tization of the synthesis of macromolecules, rather than ATP
production, explains the already-mentioned dependence of
activated lymphocytes on aerobic glycolysis. In other words,
the cell replaces its previous efficient ATP production (resting
state) with efficient and rapid macromolecule biosynthesis
(activated state) [11].
Additional support for the finding that cell metabolism
is a key regulator of lymphocyte function and differentiation
[11] has been provided by the patterns of “fuel usage” and
transcriptional and posttranscriptional factors that control
metabolism in the various activatedT cell lineages.Thehelper
T cell lineages Th1, Th2, and Th17 all exhibited increased
aerobic glycolysis (as previously mentioned for activated
lymphocytes), the posttranscriptional regulatormTORC1was
found to control glucose metabolism inTh1 andTh17 T cells,
whereas mTORC2 controlled glucose in Th2 cells [9]. Th17
glucose metabolism is also controlled by the transcriptional
regulator HIF-1𝛼 [9]. T regulatory (Treg) cells exhibit lipid
oxidation as a primary metabolic phenotype, which is con-
trolled by AMPK. Similarly, memory T cells also oxidize
lipids, although in these cells, this metabolic phenotype is
controlled by the posttranscriptional regulators TRAF6 and
AMPK [11].
2. Lymphocyte Metabolic
Dysregulation and Disease
The signals and stimuli that normally control the immune
system (IS) can be affected by conditions such as obesity and
type 2 diabetes (T2D) [12]. In this sense, it was proposed that
the direct control of lymphocyte metabolism mediated by
survival and activity-related signaling pathways could intro-
duce the potential for metabolic changes to promote diseases
[10]. More specifically, the inability of cell metabolism to
meet the energetic and biosynthetic demands of lymphocytes
could disrupt immune functionality, a process that has been
observed in several immunological diseases [10].
For example, the inhibition of glycolytic metabolism can
suppress cell proliferation and cytokine production and also
compromise effector T cell differentiation [13]. In contrast,
mitogen-induced T cell activation can reflect the glycemic
statuses and insulin levels of type 1 diabetes and T2D patients
[14]. Furthermore, hyperglycemia and ketoacidosis were
found to increase the levels of proinflammatory cytokines and
the numbers of activated T lymphocytes in diabetic patients
[14].
Lymphocyte metabolic and/or functional dysregulation
has been observed in a diet-induced obesity (DIO) model
[15]. These phenomena were reported to promote reduc-
tions in the Treg and Th2 cell populations and increases
in the resident inflammatory lymphocyte population [15].
Similarly, our laboratory recently reported that dendritic cells
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cultivated under leptin-free conditions exhibited a different
phenotype from that of wild type cells; this phenotype
was characterized by a reduced ability to induce CD4+ cell
proliferation, while inducing increased Treg and Th17 cell
differentiation [16].These results proved useful for increasing
our understanding of whether leptin can induce beneficial
(increased Treg cell numbers) or detrimental (increasedTh17
numbers) clinical outcomes [16].
In lymphocytes from Graves’ disease patients, the max-
imal activity levels of HK, G6PDH, CS, and GLUTase were
all reduced [17]. In vitro, thyroid hormones were found to
increase glucose and glutamine metabolism in the lympho-
cytes from these patients [17]. Additionally, it was reported
that concomitant acute and chronic infections in patients
with several diseases, such as cancer or asthma, are associated
with an imbalance of T1 (T helper type 1 and T cytotoxic type
1) and T2 (T helper type 2 and T cytotoxic type 2) immune
functions [18, 19].
In graft-versus-host disease (GVHD), T lymphocytes
are activated within a systemic inflammatory environment
containing ubiquitous antigens [20]. One of the few studies
that investigated T lymphocyte metabolism in vivo demon-
strated that cells activated under GVHD conditions became
highly dependent on lipidmetabolism, rather than exhibiting
the expected increase in glycolytic metabolism [20]. In
accordance with the results of that study, the FA metabolism
dependence of allogeneic T cells distinguishes these cells
metabolically fromother activatedT cell subsets, thus provid-
ing targets for therapeutic intervention (e.g., blockade of FA
transport, inhibition of FA oxidation, and limitation of fuel
sources) [20].
Cancer is another condition associated with inflam-
mation. In fact, the concept that an inflammatory tissue
injury could induce neoplasia and the existence of a close
relationship between carcinogenesis and inflammation were
initially postulated by the Greek physician Galenus approxi-
mately 2000 years ago [21]. Current estimations suggest that
approximately 25%of cancers require a chronic inflammatory
microenvironment for development [21]. Additionally, obe-
sity, which is associated with chronic low-grade inflamma-
tion, increases the risk of developing certain types of cancers
[22].
Therefore, in accordance with the hypothesis suggested
by Caro-Maldonato and coworkers [10], lymphocytes from
animals and humans with cancer are expected to exhibit
metabolic dysregulation or mismatches. In fact, cells from
primary effusion lymphoma (PEL), a subtype of B cell
non-Hodgkin’s lymphoma with a median patient survival
duration of 6 months, provide support for this hypothesis
[23]. In vitro, these cells exhibit an increased dependence on
aerobic glycolysis through the PI3 K/AKT/mTOR pathways
that control glycolysis via GLUT1 [24]. Additionally, PEL cells
actively convert glucose to FAs via increased FA synthase
activity. In fact, these cells, as well as those from other B
cell non-Hodgkin’s lymphoma subtypes, are dependent on
FA synthase to such an extent that Bhatt and coworkers [23]
suggested the possibility of using this enzyme as a unique
molecular treatment target in these cancers.
Three possible outcomes of the occurrence of a mismatch
or insufficient fuel usage in T lymphocytes were described
[10]. The first was altered or inhibited Th1, Th2, and Th17
differentiation. The second was the inhibition of prolifera-
tion or induction of cellular senescence. The third was the
induction of cell death. In accordance with these results, the
above-described outcomes for T and B lymphocytes have
been observed in several immunological diseases and have
also provided opportunities to selectively modulate specific
immune functions by targeting glucose, lipid, and amino acid
metabolism [10].
3. Mediators of Exercise-Induced
Immunomodulation
3.1. Catecholamines and Cortisol. The studies mentioned in
this section were designed in accordance with two main
research approaches that have been proposed to establish a
link between exercise and the IS: ametabolic approach, which
considers plasma glutamine concentrations/metabolism, and
a neuroendocrine approach, which considers changes in the
levels of immunomodulatory hormones and neurotransmit-
ters [25].
Interestingly, in vitro studies demonstrated that the “stress
hormones” adrenaline and cortisol are able to modulate
lymphocyte metabolism. The organism exerts tight control
over the internal environment, and any subtle disruption of
the regulated limits triggers physiological feedback mecha-
nisms to reestablish the internal milieu [26]. Among these
mechanisms is integration of the nervous and endocrine
systems (or the neuroendocrine system, NES) with IS [27],
which is systematically controlled by the NES [26]. Of note,
the integrated communication between the NES and the IS
possibly consists of the sharing of common signaling proteins
and their corresponding receptors [28, 29].
In the face of any stimuli able to disrupt homeostasis,
the response of the NES is invariably (regardless of the
nature of the stress) the same: activation of the sympa-
thoadrenal (SA) system and consequent release of cate-
cholamines (i.e., adrenaline and noradrenaline) and acti-
vation of the hypothalamic-pituitary-adrenal (HPA) axis,
which, in humans, results in cortisol production and release
[30, 31].
The stereotypic response of the NES to stress [32] aids in
understanding of the effects of exercise upon the IS because
among the several molecules (e.g., hormones, cytokines)
able to affect immune cell function, catecholamines, and
cortisol appear to be particularly involved in exercise-
induced immune responses [33]. Specifically, activation of the
SA system occurs several seconds after exercise initiation,
whereas the HPA response and the secretion of cortisol often
need 20–30 minutes before beginning [34]. Additionally,
catecholamines appear to be responsible for the initial effects
of acute exercise on the IS (e.g., the migration of lymphocyte
subpopulations) [35], whereas cortisol appears to exert its
effects within a period of at least 2 hours [35].
An interesting feature of exercise is that in accordance
with Fragala et al.’s [36] work exercise presents a unique stress
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on the homeostatic conditions, and this stress is specific to
the nature and configurations of the protocol and associated
elements (i.e., the environmental conditions or nutritional
status). That is, the magnitude of NES activation in response
to exercise stress is determined by the intensity and duration
of such exercise [37]. Consequently, the exercise protocols
that most affect the IS are those in which the intensity and
duration (acute variables) and frequency (chronic variable)
are higher. Not surprisingly, aerobic exercise protocols with
longer durations (>1.5 hours) and greater intensities (55/60–
75% of VO
2
max) induce greater release of catecholamines
and cortisol in comparison with aerobic exercise at lower
intensity [38].
Discussing the effects of different intensities, durations,
and modes of exercise on the response of the NES is
obviously beyond the scope of this review. However, briefly,
noradrenaline presents a curvilinear increase in response
to acute exercise as workload augments, while adrenaline
increases at workloads over 60% VO
2
max [39]. Regarding
cortisol, mild-intensity, moderate-duration aerobic exercise
does not appear to alter its levels. However, exercises with
intensity above 85% VO
2
max [40, 41] or with a duration
greater than 60 minutes [42] typically lead to increases in
cortisol secretion.
Rosa and coworkers [43] previously demonstrated the
ability of adrenaline to increase the proliferative index of
mesenteric lymphocytes and to concomitantly augment the
maximal activities of HK, GLUTase, and CS, as well as
glucose and glutamine consumption. However, the excess of
systemic catecholamines induced by high-intensity, exhaus-
tive exercise could have an immunosuppressive effect, such
as a reduction in the plasma levels of interferon-𝛼 (IFN𝛼)
and an antiviral cytokine [44]. In addition to its antiviral
property, IFN𝛼 has antiapoptotic and antiproliferative effects
on activated lymphocytes [45]. Regarding the effects of this
cytokine on lymphocyte metabolism, we demonstrated that
the ability of IFN𝛼 to limit T and B cell proliferation could
be explained by the suppression of glucose and glutamine
metabolism and reducedmaximalG6PDH,CS, andGLUTase
activities [46].
The immunosuppressive effect of glucocorticoids on
mesenteric lymphocytes is associated with a 40% reduction
in pyruvate utilization due to inhibition of pyruvate dehydro-
genase’s maximal activity [47].
Additionally, as mentioned, cortisol increases are typi-
cally observed during high-intensity exercises. We recently
demonstrated that basketball players participating in an offi-
cial game (stressful exercise) presented increases in salivary
cortisol and a reduction in levels of interleukin (IL)-21, a
cytokine that stimulates immunoglobulin A-secreting cells
[48]. Additionally, in accordance with the immunosuppres-
sive ability of cortisol, it was observed that the numbers and
proliferative ability of circulating lymphocytes are affected by
a single bout of intense exercise [38]. For example, a 30–50%
decrease in the lymphocyte count occurs at 30 minutes after
exercise [38].
Regarding the proliferative index of lymphocytes, our
results demonstrated that participation in very intense exer-
cise protocols, an Olympic triathlon (swimming for 1.5 km,
cycling for 40 km, and running for 10 km) [49, 50] or a
simulated cycling competition (6 sets of 20 minutes at 90%
of the individual’s anaerobic threshold) [51] reduced the
proliferative indices of T and B lymphocytes and plasma
glutamine levels.These changes were associated with reduced
cytokine production (e.g., IL-1, IL-2, IL-4, tumor necrosis
factor (TNF)𝛼, and interferon (IFN)𝛾) by mononuclear
peripheral cells in response to mitogens. It was proposed that
the IFN𝛾/IL-4 ratio in the culture supernatants of stimulated
T cells could act as an objective indicator for monitoring the
Th1/Th2 balance (cell-mediated/humoral immunity) [19]. As
such, these studies suggested that an intense bout of acute
exercise could affect this balance [19, 49–51].
Tomaintain homeostasis in the face of all organic changes
induced by physical exercise (e.g., increased body tem-
perature, dehydration, ion imbalances, hypoxia, and blood
pressure changes), other hormones (e.g., insulin, growth hor-
mone, aldosterone, glucagon, and thyroxin) are necessary in
addition to cortisol and catecholamines during exercise and
recovery [32]. Although the involvement of these hormones
in exercise’s ability to modulate the IS needs further inves-
tigation, certain evidence reinforces possible involvement.
For example, insulin can control the metabolism and func-
tionality of lymphocytes [1], and its infusion into critically
ill patients is used to achieve tight hyperglycemic control
and to fight systemic inflammation [52]. Thyroid hormones
in turn stimulate aerobic glycolysis, glutamine consumption,
and aerobic metabolism in human lymphocytes [17].
3.2. Cytokines. As previously discussed regarding the effect
of an excess of catecholamines on plasma TNF𝛼 [44], the
plasma levels of other cytokines are affected by exercise [27],
and it has been suggested that the impact of exercise on
cytokine production could partially explain how this stressor
modulates the IS [32]. Regarding this concept, the cytokine
that is most responsive to exercise is IL-6, whose levels
increase up to 100 fold as the duration of exercise progresses
[53]. Interestingly, the source of this cytokine is the skeletal
muscle [54]. The increase in IL-6 levels is followed by an
increase in the levels of an IL-1 receptor antagonist that is
an inhibitor of the inflammatory cytokines IL-1 and IL-10,
important anti-inflammatory cytokines [22].
3.3. Other Mediators. In addition to the neuroendocrine and
immune responses to exercise mentioned above, exercise
may modulate immunity in alternative ways. One of these
ways is exercise-induced muscle damage, which results in
the secretion of inflammatory cytokines by innate immune
cells [33]. Another way is the effect of exercise upon plasma
glutamine levels [55]. Thus, the reduction in the levels of
this amino acid after strenuous exercise could be related
to immunosuppression, whereas the increase in glutamine
levels induced by chronic moderate-intensity exercise would
induce a positive effect upon immune function [56].
Finally, it is worth mentioning that, in many respects, the
responses and adaptations to chronic exercise are the result
of the cumulative influence of repeated acute exercise bouts
[57].Thus, to understand how exercise training canmodulate
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lymphocyte function as well as metabolism, it is important to
know the acute effects of exercise.
4. Anti-Inflammatory and Immunomodulatory
Effects of Chronic Exercise
Regarding the chronic effects of physical exercise, the pro-
tection that it offers against all-cause mortality is known to
occur primarily due to the ability of exercise to protect against
atherosclerosis, T2D, colon cancer, and breast cancer [22].
The fact that the above-mentioned diseases seem to associate
with low-grade chronic inflammation and the finding that
acute exercise increases the systemic levels of several anti-
inflammatory cytokines (especially exercise that is not high
intensity or exhaustive) suggest the possibility that regular
exercise can protect against the chronic conditions associated
with low-grade inflammation via an anti-inflammatory effect
[22].
In accordance with certain authors, the potential under-
lying mechanisms of the anti-inflammatory effects of regular
moderate exercise primarily include a reduction in visceral
fat mass, increased production, and release of myokines and
reduced expression of Toll-like receptors on monocytes and
macrophages; however, these mechanisms likely also include
inhibition of monocyte and macrophage infiltration into
adipose tissues, a reduction in the number of circulating
proinflammatory monocytes and an increase in the number
of circulating Treg cells [58]. The modulation of lymphocyte
metabolism by exercise, however, is not included on this list.
In accordance with the proposal that regular moderate-
intensity exercise has beneficial anti-inflammatory (and
immunomodulatory) effects, it seems that when chronic,
this exercise intensity is able to reverse the age-associated
reduction in Th1 cell numbers or Th1-cell derived cytokine
levels that are normally observed in older adults [19]. More-
over, other studies have reported that moderate exercise
training increased the production ofTh1 response-associated
cytokines in both humans and rats [59–63]. Still, experimen-
tal evidence suggests that chronic moderate exercise could
normalize IL-4 concentrations and increase IL-2 concentra-
tions in a heart failure model in which the T2-type response
had been initially elevated [64].
The evidence suggests that high-intensity exercise could
be immunosuppressive [12]. It was demonstrated that when
chronic, this level of exercise stimulates a type 2 T cell
phenotype in trained individuals [19] and that this tendency
might be associated with the high incidence of upper res-
piratory infection episodes among athletes [12]. In fact, two
recent studies have suggested that lifelong participation in
high volumes of intense exercise could compromise immune
functionality [65, 66]. Together, these studies reported that
young athletes had fewer CD4+ T lymphocytes and that
these cells exhibited reduced functionality and a higher
degree of differentiation in comparison with those from
young nonathletes. Regarding CD8+ T lymphocytes, it was
observed that despite, the higher number of these cells, there
was a lower frequency of thymic emigration [65]. However,
this altered lymphocyte functionality observed in young
athletes was not found in elderly athletes; however, in the
latter group, natural killer cells exhibited increased activation
and degranulation. Therefore, it is possible that, in elderly
individuals, the IS can adapt itself to the detrimental effects
of lifelong exhaustive exercise [65].
Together, these studies suggest that chronic exercise
affects lymphocyte functioning. Thus, considering the strict
relationship between function and metabolism in these cells,
it is important to understand howglucose and glutamine con-
sumption in lymphocytes is modulated by regular moderate-
and high-intensity exercise.
5. Chronic Exercise-Mediated Modulation of
Lymphocyte Nutrient Metabolism
Evidence suggests that these effects of exercise are at least
partly due to the ability of exercise to modulate cell nutri-
ent metabolism and particularly glucose and glutamine
metabolism.
For example, Navarro and colleagues [67] demonstrated
the ability of chronic moderate-intensity exercise (eight
weeks of treadmill running) to modulate the activation, pro-
liferation, cytokine production, and glucose and glutamine
metabolism of T and B lymphocytes.
In support of the statement that lymphocytes utilize
glucose and glutamine at high rates according to their spe-
cific immune functions [68], the exercise-induced metabolic
changes observed by Navarro and colleagues [45] were
accompanied by concomitant alterations in functionality. For
example, increased expression of IL-2 and its receptor (IL-
2R) and decreased expression of IL-4 and its receptor (IL-4R)
were observed in T cells relative to B lymphocytes.These data
suggest that chronic moderate exercise in healthy animals
primarily enhances the Th1 response phenotype [67]. As
several immunological disorders have been associated with
a dysregulated Th1/Th2 balance [69], this is an important
finding.
Regarding humoral immunity, chronicmoderate exercise
was shown to increase IgG production in lymphocytes
from trained rats compared with lymphocytes from seden-
tary animals, thus indicating an improvement in humoral
immunity. In support of the finding that both cellular and
humoral immune functions improved in response to exercise,
increases in the expression and modulation of CD8, CD54,
and CD30 were observed, potentially indicating improve-
ments in both types of immunity [67].
It was observed that the changes in lymphocyte function
were accompanied by a differential effect of moderate exer-
cise on T and B lymphocyte metabolism [67]. Specifically,
T lymphocytes increased glutamine utilization by shifting
the metabolism of this amino acid to an aerobic pathway
(as previously mentioned herein, only a minor percentage
of glutamine is oxidized in lymphocytes). Concomitantly,
these cells reduced their glucose consumption and lactate
production levels (lymphocytes typically convert most of
their glucose to lactate). In contrast, B lymphocytes exhib-
ited increases in both glucose and glutamine consumption,
although only glutamine aerobic metabolism was increased
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[67]. All of these lymphocytic changes were possible because
key glucose and glutamine metabolic enzymes were targets
of the modulatory effect of chronic exercise. Therefore, in
accordance with enhanced aerobic glutamine metabolism,
the maximal activities of GLUTase and CS increased in T
lymphocytes’ response to exercise. In addition to these 2
enzymes, themaximal activities of HK andG6PDHwere also
augmented in B lymphocytes in response to chronic exercise
[67].
The effects of chronic moderate-intensity exercise were
also investigated in animal models of chronic diseases.
Recently, activated T lymphocytes were proposed as a model
to understand carcinogenesis [70].Through changes in trans-
porter expression and isozyme switching, both activated lym-
phocytes and cancer cells become highly glycolytic and glu-
tamine dependent to promote growth, proliferation, and dif-
ferentiation. Therefore, an understanding of the metabolism
of activated T cells could facilitate the identification of new
therapeutic strategies that would selectively target tumor
metabolism or inflammatory immune responses [70].
Thus, the effects of exercise were investigated in lym-
phocytes obtained fromWalker-256 tumor-bearing rats [71].
In response to the tumor, the metabolism and function of
these cells were compromised; T and B cells from the tumor-
bearing rats exhibited lower proliferative indices relative to
those of cells from sedentary animals [71] and increased
glucose consumption and lactate production in comparison
with cells from control animals. Eight weeks of moderate-
intensity treadmill running suppressed tumor growth and
reversed the repressive effects of the Walker-256 tumors on
the lymphocytes’ proliferative indices. Additionally, exercise
training reversed the effect of the tumor by reducing glucose
consumption and lactate production while counterbalancing
the effects of the disease on themaximal activities of G6PDH,
HK, and CS. Therefore, the immunomodulatory effects of
exercise were characterized by a reversion of the tumor-
induced changes. Finally, the exercise-induced effects on
lymphocyte function and metabolism were accompanied
by altered plasma hormone levels (e.g., growth hormone,
testosterone, and corticosterone) and beneficial changes in
cytokine levels (e.g., IL-1, IL-2) [71].
Rheumatoid arthritis (RA) is an autoimmune disease that
causes several disturbances in immunological functioning
[72, 73]. Previously, it had been speculated that because cer-
tain immune functions are exacerbated in RA, improved IS
functioning with exercise could theoretically be detrimental
to RA patients. However, the opposite was found to be true,
as studies performed in the 1990s regarding exercise and
inflammatory disease demonstrated that nearly any type of
exercise was superior to a sedentary lifestyle for RA patients
[74, 75]. Additionally, it was observed that exercise appeared
to be beneficial for individuals with RA because of its anti-
inflammatory effects [22, 74].
Therefore, we decided to verify whether alterations in
glucose and glutamine metabolism were present in a model
of experimental arthritis (collagen-induced arthritis, CIA)
and whether a chronic swim training regimen could coun-
terbalance the deleterious effects of RA by modulating the
metabolism of these nutrients [62]. Initially, we observed
that lymphocytes from CIA animals consumed more glu-
cose, despite exhibiting reduced lactate production rela-
tive to lymphocytes from healthy animals, thus indicating
that CIA induced “defective” lymphocyte activation [62].
Additionally, CIA reduced glutamine consumption and glu-
tamate/aspartate production, and these metabolic changes
were associated with an elevated proliferative index in the
cells from CIA animals. However, an eight-week moderate-
intensity swim training regimen reduced the proliferative
index and glucose consumption of lymphocytes from theCIA
animals and increased their glutaminemetabolism (Figure 1).
To obtain a more complete understanding of the
immunomodulatory effects of exercise, we also analyzed
the plasma levels of certain hormones. Trained CIA rats
exhibited lower levels of the proinflammatory hormone pro-
lactin and higher levels of the immunosuppressive hormones
progesterone and corticosterone [62]. Interestingly, chronic
exercise also increased the plasma levels of IL-2, a cytokine
that can both initiate and terminate inflammation under
different conditions, as well as increased plasma levels of
glutamine [76]. Taken together, the data from the trained
CIA animals suggested that the ability of swim training
to counterbalance several effects of CIA resulted from the
modulation of lymphocyte metabolism and the balance
between proinflammatory and anti-inflammatory hormones
and cytokines.
Despite the common belief that high-intensity exercise is
immunosuppressive [12], it is important to note that, in this
case, “high intensity”means chronic exercise of high intensity
and volume, such as those physical training regimens used
by athletes [12]. That is, it is possible to speculate that high-
intensity exercise at a low/moderate volume would induce
beneficial effects on the IS because this type of exercise would
allow the organism to become adapted to it.
In support of this speculation, an eight-week anaerobic
jumping training (a high-intensity exercise) regimen was
reported to increase the expression of the proapoptotic
protein Bax and reduce the expression of the antiapoptotic
protein Bcl-2; these findings were associated with reduced
Walker-256 tumor growth consequent to apoptosis [77]. The
authors attributed their findings to unknown interference
in the Walker-256 tumor cells. Subsequently, our group
observed that Walker-256 tumor-bearing rats subjected to
high-intensity running training for an 8-week period (85%
VO
2
max thirty minutes per day for five days) exhibited a
40% reduction in tumor growth and a 35.5% increase in
lifespan relative to sedentary, tumor-bearing rats [63]. These
changes were accompanied by reduced lactate production in
the Walker-256 tumor cells, suggesting that the tumor cells
had become less glycolytic. Moreover, in the trained animals,
the tumor cells exhibited increased glutamine consumption
and glutamate and aspartate production. Despite these find-
ings, glutamine consumption due to aerobic metabolism was
reduced [63].
Regarding lymphocyte function and metabolism, the
same study demonstrated that the exercise training protocol
counterbalanced the effects of the Walker-256 tumors on
lymphocyte metabolism [63]. Lymphocytes from trained
animals exhibited an increased proliferative index, reduced
Mediators of Inflammation 7
Glucose
Glucose-6-phosphate
Pyruvate
GlycolysisKrebs cycle
Predominance 
of biosynthesis 
of macromolecules
Glutamine
• Hepatitis
• Cancer
• HIV
Infections
• Viruses
• Bacteria
• Fungi
• Parasites
Autoimmune diseases
• Type 1 diabetes
• Lupus
• Rheumatoid 
arthritis
Allergies
• Asthma
• Sinusitis
Immune underfunctioning Immune overfunctioningChronic exercise balanced immune system
Activated
lymphocyte
Chronic diseases
Figure 1: Exercise counterbalances lymphocyte metabolic dysregulation, modulating several components of glycolysis and glutaminolysis.
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glucose consumption (aerobic and anaerobic), and reduced
lactate production in comparison with immune cells from
sedentary, tumor-bearing rats. Similarly, the high-intensity
exercise program reversed the tumor-induced effects on
glutaminemetabolism [63]. Notably, themodulatory effect of
exercise was accompanied by increased cytokine levels (e.g.,
IL-1, IL-2, and TNF𝛼) and changes in plasma hormone levels
(e.g., increased corticosterone levels, reduced growth hor-
mone levels) [63]. Therefore, the immunomodulatory effects
of exercise occurred in response to a complex interaction of
hormones, cytokines, and metabolic changes.
6. Conclusion
Acute exercise and chronic exercise affect lymphocyte func-
tion in a manner associated with the modulation of glucose
and glutamine metabolism. Although further studies are
necessary, the primary experimental evidence suggests that
the well-known anti-inflammatory and immunomodulatory
effects of exercise are at least partly characterized by the abil-
ity of chronic exercise to adjust the energetic and biosynthetic
demands of lymphocytes in response to physiological and
pathological conditions.
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